Core Competencies
BRCR Global supports the US Government in its mission to develop medical countermeasures and advancements that address the public health by providing:
First-in-Human to Phase IV, clinical trial management: Extensive experience in conducting clinical trials during public emergencies; offering consistent operations, robust change control, and continuous improvement from start-up to closeout.
Patient Recruitment and Retention: Effective strategies with over 10,000 participants engaged, meeting key performance indicators.
Research Sites and Network: State-of-the-art sites in Florida, Puerto Rico, Texas, and Louisiana, as well as a network of 350+ clinics for trial implementation.
Regulatory Compliance: Adherence to FDA regulations and ICH-GCP guidelines.
Quality and Risk Management: Integration of Continuous Quality Improvement (CQI) strategies.
Differentiators
BRCR completed 2,311 clinical trials using the BRCR Full-Start Up Process™. This method fosters a culture of collaboration and excellence, ensuring swift, high-quality trial execution, and enhanced stakeholder coordination.
Through the onboarding program, BRCR Global ProTraining™ tracks metrics such as a 95% training completion rate, an 85% certification achievement, and a 20% post-training performance improvement to assess effectiveness.
The robust Internal BRCR Global PrimeQMS™ monitors KPIs such as 98% protocol adherence, 100% regulatory compliance, and 90% satisfaction ratings to uphold high standards.
Company Data
- Legal Name: BRCR Medical Center, Inc
- DBA: BRCR Global
- SAM UEI: LZ8YBPFU5ML9
- CAGE: 9TXU5
- NAICS: 541714
Past Performance
TigerMed
TigerMed highlighted our speed and reliability, giving start-up time 90% (very good) and completion time 100% (exceptional). They also noted, “Your startup timelines are very fast, friendly team to work with, and always communicating and going above and beyond when needed.” Communication effectiveness was also rated 100% (exceptional), with TigerMed saying, “I’m in constant contact with the Business Development department, and they’re always responding to me and my team in a timely manner.” TigerMed rated overall services and willingness to engage for future trials 100% (exceptional), reflecting strong satisfaction and confidence in our work.
Major Sponsor based in Suzhou, China
Major Sponsor based in Suzhou provided ratings for both data accuracy and issue resolution, reflecting adequate execution but also areas for improvement. Team integration was rated 90% (very good). Communication effectiveness, one remark stated, “I’ve been very impressed with the new study-level CRC who asks real-time questions and provides timely updates and feedback.” Completion time and overall satisfaction recognized our proactive approach and collaborative management style, they mentioned, “Management has been very open and collaborative,” reinforcing the success of our partnership despite noted areas for improvement.
Major Sponsor based in Shanghai, China
A major CRO headquartered in Shanghai, China highlighted our 100% (exceptional) performance in start-up time and completion time, specifically noting, “Impressed with BRCR in trying to help us in enrollment.” However, their feedback reflected potential areas for improvement in communication effectiveness, signaling a need for greater clarity and consistency. While trial management effectiveness indicated contentment with our services, they also recognized opportunities for further improvement. They noted that our team and Principal Investigator remained engaged and dedicated to the trial’s success.
Major CRO based in Shanghai, China
Major CRO based in Shanghai, China rated the overall performance of the trial exceptionally high across all categories, with 100% ratings in both data accuracy and issue resolution, demonstrating the reliability and quality of our services. Start-up time was rated 100% (exceptional), while completion time was rated 90% (very good), indicating strong efficiency with a slight opportunity for further enhancement. They also gave 100% ratings in willingness to engage for future trials and overall satisfaction, reflecting their complete confidence in our capabilities.
